Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: PLOS Pathogens, 13, 4, S. e1006386-
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg, Public Library of Science (PLoS)
- (when)
-
2017
- Creator
-
Rose, Jessica
Emery, Vincent C.
Kumar, Deepali
Asberg, Anders
Hartmann, Anders
Jardine, Alan G.
Bignamini, Angelo A.
Humar, Atul
Neumann, Avidan U.
- DOI
-
10.1371/journal.ppat.1006299
- URN
-
urn:nbn:de:bvb:384-opus4-823702
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:46 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rose, Jessica
- Emery, Vincent C.
- Kumar, Deepali
- Asberg, Anders
- Hartmann, Anders
- Jardine, Alan G.
- Bignamini, Angelo A.
- Humar, Atul
- Neumann, Avidan U.
- Universität Augsburg, Public Library of Science (PLoS)
Time of origin
- 2017
Other Objects (12)
Activation and inhibition of caspase-2 during human cytomegalovirus infection
Modulation of extramedullary hematopoiesis during cytomegalovirus infection
Host factors contributing to human cytomegalovirus infection
Factors defining the immunodominance hierarchy during cytomegalovirus Infection
Cytomegalovirus Infection of the Rat Developing Brain In Utero Prominently Targets Immune Cells and Promotes Early Microglial Activation
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Control of Murine Cytomegalovirus Infection by γδ T Cells
The human cytomegalovirus infection : a risk factor in atherogenesis
Control of latent cytomegalovirus infection by type I interferons
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Screening and characterization of novel chemical compounds inhibiting cytomegalovirus infection
Screening and characterization of novel chemical compounds inhibiting cytomegalovirus infection
Activation and inhibition of caspase-2 during human cytomegalovirus infection
Modulation of extramedullary hematopoiesis during cytomegalovirus infection
Host factors contributing to human cytomegalovirus infection
Factors defining the immunodominance hierarchy during cytomegalovirus Infection
Cytomegalovirus Infection of the Rat Developing Brain In Utero Prominently Targets Immune Cells and Promotes Early Microglial Activation
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Control of Murine Cytomegalovirus Infection by γδ T Cells
The human cytomegalovirus infection : a risk factor in atherogenesis
Control of latent cytomegalovirus infection by type I interferons
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Screening and characterization of novel chemical compounds inhibiting cytomegalovirus infection
Screening and characterization of novel chemical compounds inhibiting cytomegalovirus infection
Activation and inhibition of caspase-2 during human cytomegalovirus infection
Modulation of extramedullary hematopoiesis during cytomegalovirus infection
Host factors contributing to human cytomegalovirus infection
Factors defining the immunodominance hierarchy during cytomegalovirus Infection
Cytomegalovirus Infection of the Rat Developing Brain In Utero Prominently Targets Immune Cells and Promotes Early Microglial Activation
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Control of Murine Cytomegalovirus Infection by γδ T Cells
The human cytomegalovirus infection : a risk factor in atherogenesis
Control of latent cytomegalovirus infection by type I interferons
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Screening and characterization of novel chemical compounds inhibiting cytomegalovirus infection